COMT and schizophrenia: Given the key role of the COMT enzyme in dopamine degradation [40], the significant association between rs4818 and the total PANSS score in our model suggests that this SNP may serve as a potential genetic marker for treatment response to antipsychotics in patients with schizophrenia, consistent with findings from previous studies [40,41].